Apheresis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Favourable Reimbursement Scenario in Developed Regions Supporting Steady Growth of Apheresis Market

The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market. Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which alleviates high-cost concerns regarding apheresis procedures.

Lack of regular blood donors is being countered by private blood collection centres that attract donors through paid plans. In recent times, hospitals are increasing the adoption of apheresis equipment to collect and store required blood components, so as to reduce dependency on private suppliers and blood collection centres. Given the influence of these dynamics, research by Fact.MR projects the apheresis market to grow 2X during the forecast period (2020 - 2025).

For detailed insights on market taxonomy, request a sample copy of the report here.

Shift from Single Dose to Double Dose Apheresis to Create Opportunities for Disposable Products

The healthcare sector is constantly plagued by a disproportionately high unmet need for blood components. As a result, a shift away from single dose towards double dose apheresis is observed to increase the yield of blood components. The shift is also creating an indispensable need to separate multiple components at once, which is driving the development of advanced products such as plasma separators and immunoadsorbent. The trend of adopting double dose apheresis procedures is specifically dominant in Japan, Germany, and the U.S. markets.

Disposables will remain preferred products in the apheresis market over devices, as advancements in apheresis equipment differentiate the types of columns, blood lines, and tubing. In addition, the frequency of use of these products is comparatively higher than the adoption of devices, which is projected to retain lucrative prospects from the sales of disposable products.  

New Revenue Streams for Apheresis Procedures from Expansion of Application Scope

According to guidelines for apheresis procedures as provided by the American Society for Apheresis (ASFA), there are over 87 diseases that can be treated using the apheresis procedure as the sole line or as supportive treatment. Manufacturers of apheresis equipment are capitalizing on this opportunity to foster innovation in these products, and validate them based on evidence to target novel applications.

Among other applications, evidence-based use of apheresis procedures for neurological applications is projected to create a significant revenue stream for the apheresis market. Moreover, increasing use of radiotherapy or chemotherapy and incidence of damaged bone marrow are likely to unlock profitable avenues from apheresis procedures used for the treatment of cancer.

Understanding Impact of Underlying Challenges Present in Apheresis Market

Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape, which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals. Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in turn, its operations. However, scarcity of expert operators leads to an increase in acquisition cost of well-informed resources, which adds up to the already high cost of apheresis procedures.

Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and reimbursement programs. However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market, though these present highly lucrative, yet largely untapped markets.

For detailed regional analysis, request a sample copy of the report here.

Cost-competitiveness - A Key Strategy to Grow in Developing Regions

High technological prowess coupled with government aid supporting research & development activities is increasing the concentration of manufacturers in North America. Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’ reliance on hospitals and clinics. Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by market players, further expands the patient pool in the region. Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering a CAGR of ~10% during the forecast period.

Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market. Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players adopt a cost-competitive strategy to achieve better penetration rate of products in these regions.

Request research methodology of this report.